Redmile Group, LLC Diversified Active

Location: Larkspur, CA

CIK: 0001425738 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $1.028B (100.0% shares, 0.0% debt)

Holdings (40)

SRRK SCHOLAR ROCK HLDG CORP 14.1%

Value $145M Shares 3,904,456 Est. Cost $12.18 Unrealized +187.1%

KRYS KRYSTAL BIOTECH INC 11.4%

Value $117M Shares 661,388 Est. Cost $58.73 Unrealized +154.9%

STOK STOKE THERAPEUTICS INC 9.5%

Value $98.13M Shares 4,175,542 Est. Cost $9.00 Unrealized +90.4%

ZYME ZYMEWORKS INC 6.2%

Value $63.29M Shares 3,705,750 Est. Cost $7.05 Unrealized +103.1%

ADCT ADC THERAPEUTICS SA 6.1%

Value $62.67M Shares 15,666,731 Est. Cost $19.52 Unrealized -83.9%

IMNM IMMUNOME INC 5.7%

Value $58.82M Shares 5,023,385 Est. Cost $10.65 Unrealized -6.6%

LIVN LIVANOVA PLC 4.7%

Value $48.55M Shares 926,799 Est. Cost $70.40 Unrealized -28.5%

RGNX REGENXBIO INC 4.4%

Value $45.29M Shares 4,693,389 Est. Cost $22.74 Unrealized -61.1%

— AKERO THERAPEUTICS INC 3.5%

Value $35.51M Shares 747,818 Est. Cost $33.38 Unrealized —

NRIX NURIX THERAPEUTICS INC 3.3%

Value $33.99M Shares 3,678,394 Est. Cost $20.56 Unrealized -49.5%

BEAM BEAM THERAPEUTICS INC 3.3%

Value $33.68M Shares 1,387,559 Est. Cost $26.47 Unrealized -24.8%

COGT COGENT BIOSCIENCES INC 3.1%

Value $31.72M Shares 2,209,118 Est. Cost $9.95 Unrealized +19.0%

ABSI ABSCI CORPORATION 2.4%

Value $25.09M Shares 8,253,316 Est. Cost $19.01 Unrealized -85.5%

NGNE NEUROGENE INC 2.2%

Value $22.51M Shares 1,299,022 Est. Cost $21.64 Unrealized -7.2%

— 89BIO INC 2.1%

Value $21.66M Shares 1,473,136 Est. Cost $11.28 Unrealized —

IDYA IDEAYA BIOSCIENCES INC 2.0%

Value $20.19M Shares 742,017 Est. Cost $27.49 Unrealized -12.0%

ANNX ANNEXON INC 1.9%

Value $19.22M Shares 6,300,644 Est. Cost $13.35 Unrealized -81.4%

FATE FATE THERAPEUTICS INC 1.6%

Value $16.22M Shares 12,872,946 Est. Cost $13.12 Unrealized -91.8%

RAPT RAPT THERAPEUTICS INC 1.4%

Value $14.25M Shares 552,594 Est. Cost $7.63 Unrealized +71.5%

STTK SHATTUCK LABS INC 1.3%

Value $13.24M Shares 5,539,724 Est. Cost $32.14 Unrealized -96.2%

SLDB SOLID BIOSCIENCES INC 1.1%

Value $11.72M Shares 1,899,342 Est. Cost $4.65 Unrealized +25.7%

SLN SILENCE THERAPEUTICS PLC 1.1%

Value $11.24M Shares 2,164,777 Est. Cost $18.53 Unrealized —

NUVB NUVATION BIO INC 1.1%

Value $11.21M Shares 3,031,009 Est. Cost $11.18 Unrealized -75.6%

KROS KEROS THERAPEUTICS INC 0.9%

Value $8.741M Shares 552,506 Est. Cost $59.30 Unrealized -75.1%

CLDX CELLDEX THERAPEUTICS INC NEW 0.8%

Value $8.46M Shares 327,008 Est. Cost $11.60 Unrealized +99.8%

ATRA ATARA BIOTHERAPEUTICS INC 0.6%

Value $6.33M Shares 441,701 Est. Cost $15.04 Unrealized -23.5%

FOLD AMICUS THERAPEUTICS INC 0.6%

Value $6.124M Shares 777,178 Est. Cost $10.35 Unrealized -31.2%

ALXO ALX ONCOLOGY HLDGS INC 0.6%

Value $6.099M Shares 3,332,983 Est. Cost $15.46 Unrealized -94.4%

ESTA ESTABLISHMENT LABS HLDGS INC 0.5%

Value $5.303M Shares 129,364 Est. Cost $44.21 Unrealized -7.6%

CBLL CERIBELL INC 0.5%

Value $5.001M Shares 435,239 Est. Cost $27.25 Unrealized -50.5%

XERS XERIS BIOPHARMA HOLDINGS INC 0.4%

Value $3.672M Shares 451,099 Est. Cost $2.16 Unrealized +207.6%

VTYX VENTYX BIOSCIENCES INC 0.3%

Value $3.338M Shares 1,073,386 Est. Cost $2.09 Unrealized +26.9%

— LAVA THERAPEUTICS NV 0.3%

Value $3.236M Shares 2,074,372 Est. Cost $15.19 Unrealized —

— REPARE THERAPEUTICS INC 0.3%

Value $2.792M Shares 1,586,174 Est. Cost $30.51 Unrealized —

IVVD INVIVYD INC 0.2%

Value $2.514M Shares 2,285,320 Est. Cost $18.61 Unrealized -95.2%

PLRX PLIANT THERAPEUTICS INC 0.2%

Value $2.356M Shares 1,591,695 Est. Cost $22.82 Unrealized -93.3%

REPL REPLIMUNE GROUP INC 0.2%

Value $2.245M Shares 535,818 Est. Cost $16.51 Unrealized -61.3%

PRME PRIME MEDICINE INC 0.0%

Value $483K Shares 87,118 Est. Cost $14.27 Unrealized -71.5%

KLRS KALARIS THERAPEUTICS INC 0.0%

Value $479K Shares 82,955 Est. Cost $9.79 Unrealized -66.2%

BOLD BOUNDLESS BIO INC 0.0%

Value $302K Shares 245,458 Est. Cost $14.25 Unrealized -91.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SRRK	SCHOLAR ROCK HLDG CORP	3,904,456	$145M	14.1%	$12.18	+187.1%	COM	80706P103
KRYS	KRYSTAL BIOTECH INC	661,388	$117M	11.4%	$58.73	+154.9%	COM	501147102
STOK	STOKE THERAPEUTICS INC	4,175,542	$98.13M	9.5%	$9.00	+90.4%	COM	86150R107
ZYME	ZYMEWORKS INC	3,705,750	$63.29M	6.2%	$7.05	+103.1%	COM	98985Y108
ADCT	ADC THERAPEUTICS SA	15,666,731	$62.67M	6.1%	$19.52	-83.9%	SHS	H0036K147
IMNM	IMMUNOME INC	5,023,385	$58.82M	5.7%	$10.65	-6.6%	COM	45257U108
LIVN	LIVANOVA PLC	926,799	$48.55M	4.7%	$70.40	-28.5%	SHS	G5509L101
RGNX	REGENXBIO INC	4,693,389	$45.29M	4.4%	$22.74	-61.1%	COM	75901B107
—	AKERO THERAPEUTICS INC	747,818	$35.51M	3.5%	$33.38	—	COM	00973Y108
NRIX	NURIX THERAPEUTICS INC	3,678,394	$33.99M	3.3%	$20.56	-49.5%	COM	67080M103
BEAM	BEAM THERAPEUTICS INC	1,387,559	$33.68M	3.3%	$26.47	-24.8%	COM	07373V105
COGT	COGENT BIOSCIENCES INC	2,209,118	$31.72M	3.1%	$9.95	+19.0%	COM	19240Q201
ABSI	ABSCI CORPORATION	8,253,316	$25.09M	2.4%	$19.01	-85.5%	COM	00091E109
NGNE	NEUROGENE INC	1,299,022	$22.51M	2.2%	$21.64	-7.2%	COM	64135M105
—	89BIO INC	1,473,136	$21.66M	2.1%	$11.28	—	COM	282559103
IDYA	IDEAYA BIOSCIENCES INC	742,017	$20.19M	2.0%	$27.49	-12.0%	COM	45166A102
ANNX	ANNEXON INC	6,300,644	$19.22M	1.9%	$13.35	-81.4%	COM	03589W102
FATE	FATE THERAPEUTICS INC	12,872,946	$16.22M	1.6%	$13.12	-91.8%	COM	31189P102
RAPT	RAPT THERAPEUTICS INC	552,594	$14.25M	1.4%	$7.63	+71.5%	COM NEW	75382E208
STTK	SHATTUCK LABS INC	5,539,724	$13.24M	1.3%	$32.14	-96.2%	COM	82024L103
SLDB	SOLID BIOSCIENCES INC	1,899,342	$11.72M	1.1%	$4.65	+25.7%	COM NEW	83422E204
SLN	SILENCE THERAPEUTICS PLC	2,164,777	$11.24M	1.1%	$18.53	—	ADS	82686Q101
NUVB	NUVATION BIO INC	3,031,009	$11.21M	1.1%	$11.18	-75.6%	COM CL A	67080N101
KROS	KEROS THERAPEUTICS INC	552,506	$8.741M	0.9%	$59.30	-75.1%	COM	492327101
CLDX	CELLDEX THERAPEUTICS INC NEW	327,008	$8.46M	0.8%	$11.60	+99.8%	COM NEW	15117B202
ATRA	ATARA BIOTHERAPEUTICS INC	441,701	$6.33M	0.6%	$15.04	-23.5%	COM NEW	046513206
FOLD	AMICUS THERAPEUTICS INC	777,178	$6.124M	0.6%	$10.35	-31.2%	COM	03152W109
ALXO	ALX ONCOLOGY HLDGS INC	3,332,983	$6.099M	0.6%	$15.46	-94.4%	COM	00166B105
ESTA	ESTABLISHMENT LABS HLDGS INC	129,364	$5.303M	0.5%	$44.21	-7.6%	COM	G31249108
CBLL	CERIBELL INC	435,239	$5.001M	0.5%	$27.25	-50.5%	COM	15678C102
XERS	XERIS BIOPHARMA HOLDINGS INC	451,099	$3.672M	0.4%	$2.16	+207.6%	COM	98422E103
VTYX	VENTYX BIOSCIENCES INC	1,073,386	$3.338M	0.3%	$2.09	+26.9%	COM	92332V107
—	LAVA THERAPEUTICS NV	2,074,372	$3.236M	0.3%	$15.19	—	SHS	N51517105
—	REPARE THERAPEUTICS INC	1,586,174	$2.792M	0.3%	$30.51	—	COM	760273102
IVVD	INVIVYD INC	2,285,320	$2.514M	0.2%	$18.61	-95.2%	COM	00534A102
PLRX	PLIANT THERAPEUTICS INC	1,591,695	$2.356M	0.2%	$22.82	-93.3%	COM	729139105
REPL	REPLIMUNE GROUP INC	535,818	$2.245M	0.2%	$16.51	-61.3%	COM	76029N106
PRME	PRIME MEDICINE INC	87,118	$483K	0.0%	$14.27	-71.5%	COM	74168J101
KLRS	KALARIS THERAPEUTICS INC	82,955	$479K	0.0%	$9.79	-66.2%	COM	482929106
BOLD	BOUNDLESS BIO INC	245,458	$302K	0.0%	$14.25	-91.9%	COM	10170A100